(2-bromo-3,4-dimethoxy-6-methylphenyl)(3,4-dimethoxyphenyl)methanone

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2-bromo-3,4-dimethoxy-6-methylphenyl)(3,4-dimethoxyphenyl)methanone
• 英文别名: (2-Bromo-3,4-dimethoxy-6-methylphenyl)-(3,4-dimethoxyphenyl)methanone；(2-bromo-3,4-dimethoxy-6-methylphenyl)-(3,4-dimethoxyphenyl)methanone
• 化学式: C₁₈H₁₉BrO₅
• 分子量: 395.25
• InChiKey: VFDFQUQJERRRKC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  54
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  1-溴-2,3-二甲氧基-5-甲基苯 、 藜芦酸 在 磷酸 作用下， 以 三氟乙酸酐 为溶剂， 反应 2.0h， 以81%的产率得到(2-bromo-3,4-dimethoxy-6-methylphenyl)(3,4-dimethoxyphenyl)methanone
  参考文献：
  名称：

  Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice

  摘要：

  In an effort to develop novel small molecule PTP1B inhibitors, a series of bromophenol derivatives were designed, synthesized and evaluated in vitro and in vivo. All of the synthesized compounds displayed weak to potent PTP1B inhibitory activities (5.62-9625%) at 20 mu g/mL. Among these compounds, 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol (9) exhibited enhanced PTP1B inhibitory activity (IC50 = 1.50 mu M) than the lead compound BDDPM (IC50 = 2.42 mu M) and high selectivity against other PTPs (TCPTP, LAR, SHP-1 and SHP-2). Results of anti-diabetic assay using C57BL/KsJ-db/db mouse model demonstrated that compound 9 was effective at lowering blood glucose, total cholesterol and HbA1c (P < 0.01). (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.03.037

文献信息

• Discovery of novel bromophenol 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol as protein tyrosine phosphatase 1B inhibitor and its anti-diabetic properties in C57BL/KsJ-db/db mice
  作者：Bo Jiang、Shuju Guo、Dayong Shi、Chao Guo、Tao Wang

  DOI：10.1016/j.ejmech.2013.03.037

  日期：2013.6

  In an effort to develop novel small molecule PTP1B inhibitors, a series of bromophenol derivatives were designed, synthesized and evaluated in vitro and in vivo. All of the synthesized compounds displayed weak to potent PTP1B inhibitory activities (5.62-9625%) at 20 mu g/mL. Among these compounds, 3,4-dibromo-5-(2-bromo-3,4-dihydroxy-6-(isobutoxymethyl)benzyl)benzene-1,2-diol (9) exhibited enhanced PTP1B inhibitory activity (IC50 = 1.50 mu M) than the lead compound BDDPM (IC50 = 2.42 mu M) and high selectivity against other PTPs (TCPTP, LAR, SHP-1 and SHP-2). Results of anti-diabetic assay using C57BL/KsJ-db/db mouse model demonstrated that compound 9 was effective at lowering blood glucose, total cholesterol and HbA1c (P < 0.01). (C) 2013 Elsevier Masson SAS. All rights reserved.